Immunotherapy, a rapidly evolving field in medicine, has revolutionized cancer treatment by leveraging the body's immune system to fight disease. This guide aims to provide an overview of the fundamental aspects of immunotherapy, enabling physicians to better understand and apply this treatment modality in clinical practice.
Immunotherapy works on the principle of enhancing the immune system's ability to detect and destroy cancer cells. It involves the use of treatments that stimulate immune responses or counteract mechanisms that cancer cells use to evade the immune system. There are several types of immunotherapies including immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies.
Immune checkpoint inhibitors are drugs that block immune checkpoints - proteins that prevent immune cells from attacking non-harmful cells in the body. Some cancer cells exploit these checkpoints to avoid being targeted by the immune system. By blocking these checkpoints, these inhibitors enable the immune system to recognize and attack cancer cells.
Cancer vaccines, unlike traditional vaccines, are usually given after a cancer diagnosis to stimulate the immune system to attack cancer cells. They can be made from a variety of materials, including cells, proteins, or DNA, and can be patient-specific or off-the-shelf.
Adoptive cell therapies involve the use of T-cells, a type of white blood cell, to fight cancer. In some therapies, T-cells are removed from a patient, genetically modified to recognize specific cancer cells, and then infused back into the patient.
Immunotherapy represents a significant advancement in cancer treatment, offering new hope to patients with various types of malignancies. As research continues to evolve, it's crucial for physicians to stay informed about these developments to provide the best possible care for their patients. Understanding the fundamentals of immunotherapy is the first step in this important journey.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation